Spyre Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001636282-24-000021 |
2024-04-01 16:06:29 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000902664-24-001596 |
2024-02-14 09:08:19 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000902664-24-001536 |
2024-02-14 07:02:44 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000315066-24-001597 |
2024-02-09 10:20:59 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-294297 |
2023-12-13 15:50:51 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001493152-23-043412 |
2023-12-01 16:15:48 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001683168-23-008109 |
2023-11-14 15:13:25 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-264329 |
2023-10-26 21:53:28 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001172661-23-002651 |
2023-07-28 09:01:00 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000935836-23-000523 |
2023-07-18 16:01:08 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001104659-23-079663 |
2023-07-10 16:16:19 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001839882-23-017505 |
2023-07-03 16:20:04 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-180612 |
2023-06-30 17:24:26 |
SC 13D
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000935836-23-000494 |
2023-06-30 16:20:43 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001172661-23-002388 |
2023-06-30 16:00:26 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-103731 |
2023-04-17 16:47:57 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001104659-23-021466 |
2023-02-14 16:00:44 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001172661-23-001246 |
2023-02-14 14:51:18 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-23-023699 |
2023-02-03 11:43:51 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001319244-22-000177 |
2022-12-01 16:07:48 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000834237-22-009740 |
2022-06-09 15:20:05 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-22-015010 |
2022-04-21 08:30:43 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001104659-22-021612 |
2022-02-14 08:01:34 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-22-033917 |
2022-02-10 11:14:29 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000919574-21-007450 |
2021-12-16 16:32:15 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-21-019953 |
2021-04-22 08:30:12 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001104659-21-032826 |
2021-03-05 17:17:34 |
SC 13D
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001628280-21-002125 |
2021-02-12 16:59:33 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-21-035800 |
2021-02-10 11:37:58 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000834237-21-006814 |
2021-02-02 14:56:30 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000899140-20-000490 |
2020-10-26 16:36:29 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001193125-20-164398 |
2020-06-09 11:45:56 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-20-018057 |
2020-04-23 08:30:33 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-19-012157 |
2019-04-22 08:00:19 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000215457-19-006615 |
2019-02-07 18:09:33 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000902664-18-003697 |
2018-10-11 10:26:29 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-18-022770 |
2018-09-06 17:00:18 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-18-008198 |
2018-04-16 07:00:32 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001144204-18-007931 |
2018-02-13 16:16:26 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001144204-17-062996 |
2017-12-08 16:30:27 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001564590-17-006805 |
2017-04-21 08:01:19 |
DEF 14A
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001571049-17-001327 |
2017-02-14 11:40:11 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001137774-16-000248 |
2016-05-10 16:09:15 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000053417-16-000378 |
2016-05-09 14:04:58 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0000947871-16-001113 |
2016-04-18 15:24:53 |
SC 13G
|
| 1636282 |
AGLE |
Spyre Therapeutics, Inc. |
0001140361-16-061144 |
2016-04-14 17:14:10 |
SC 13G
|
